Sugi Predict

Sugi Predict / Targets / HNRNPA3

HNRNPA3

Heterogeneous nuclear ribonucleoprotein A3 · P51991 · HNRNPA3 on Sugi Atlas →

0 patent compounds predicted against HNRNPA3, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to HNRNPA3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
3K3A-APC for Treatment of Amyotrophic Lateral Sclerosis (ALS) PHASE2COMPLETED
Preventive Approach to Congenital Heart Block With Hydroxychloroquine PHASE2COMPLETED
Longitudinal Study of Neurogenetic Disorders nanRECRUITING
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity nanUNKNOWN
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS nanRECRUITING
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Immunophenotyping and Xist Gene in AML nanUNKNOWN
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Identification of New FTLD Genes nanUNKNOWN
Genetics of Familial and Sporadic ALS nanCOMPLETED
B3 for NMD: Bench to Bedside and Back nanENROLLING_BY_INVITATION
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
Predictive Value of Maternal Blood Protein Signatures in Preterm Birth nanCOMPLETED
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Better Delineation of DDX3X Related Phenotype and Epigenetic Signature. nanUNKNOWN
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer nanCOMPLETED
Na+ Channel mRNA Regulation in Heart Failure nanCOMPLETED
International PPB/DICER1 Registry nanRECRUITING
Impact of Weight Loss on the Human Sperm Epitranscriptome nanACTIVE_NOT_RECRUITING
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Brain Involvement in Myotonic Dystrophy Type I: From Functional Neuroimaging to the Impact on Quality of Life nanCOMPLETED
Characterizing the Role of Pain Sensitivity in Acute to Persistent Low Back Pain nanCOMPLETED
Prognostic Value of Protein IMP3 Expression in Cervical Cancer nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a HNRNPA3 binder may also engage these)

ProteinNameSimilarity
Q8BG05 — 1.000 Q8BG05 →
Q6URK4 — 1.000 Q6URK4 →
A7VJC2 — 1.000 A7VJC2 →
Q5RBU8 — 1.000 Q5RBU8 →
P51992 — 1.000 P51992 →
Q32P51 — 1.000 Q32P51 →
HNRNPA2B1 Heterogeneous nuclear ribonucleoproteins A2/B1 0.999 landscape →
P17130 — 0.999 P17130 →
P51968 — 0.999 P51968 →
HNRNPA1 Heterogeneous nuclear ribonucleoprotein A1 0.999 landscape →
Q9TTV2 — 0.998 Q9TTV2 →
O88569 — 0.998 O88569 →
P51989 — 0.998 P51989 →
Q28521 — 0.998 Q28521 →
Q2HJ60 — 0.997 Q2HJ60 →
P51990 — 0.997 P51990 →
A0A2R8Y4L2 — 0.997 A0A2R8Y4L2 →
A5A6H4 — 0.996 A5A6H4 →
P09867 — 0.996 P09867 →
P21522 — 0.996 P21522 →
P04256 — 0.996 P04256 →
P49312 — 0.994 P49312 →
HNRNPA0 Heterogeneous nuclear ribonucleoprotein A0 0.993 landscape →
P48810 — 0.992 P48810 →
Q22037 — 0.990 Q22037 →
Q9CX86 — 0.989 Q9CX86 →
Q27294 — 0.984 Q27294 →
P07909 — 0.984 P07909 →
Q94KD0 — 0.983 Q94KD0 →
Q3SWU3 — 0.983 Q3SWU3 →